[Efficacy and safety of indapamide 1.5 mg sustained release coated tablets in the therapy of arterial hypertension]
用户o-eYZirgPGyk
1个月前
116
10
已关闭
DOI:
文献链接: https://pubmed.ncbi.nlm.nih.gov/9772936
其他信息:
PMID: 9772936
作者: R Asmar; R Asmar; R Asmar
摘要: Objective: In line with international recommendations concerning the need to decrease the doses of antihypertensives, a low dose form (1.5 mg) of indapamide, sustained release coated tablet (SR), has been developed in order to optimize the efficacy-safety ratio while maintaining a once daily dosage. The objective of this study was to evaluate the benefit obtained by reviewing the results of two clinical trials conducted according to a similar methodology.
